Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $36.0 million.

  • Cumberland Pharmaceuticals' Non-Current Assets fell 13.37% to $36.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year decrease of 13.37%. This contributed to the annual value of $39.1 million for FY2024, which is 15.05% down from last year.
  • Cumberland Pharmaceuticals' Non-Current Assets amounted to $36.0 million in Q3 2025, which was down 2.02% from $36.7 million recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Non-Current Assets peaked at $51.4 million during Q1 2022, and registered a low of $36.0 million during Q3 2025.
  • Moreover, its 3-year median value for Non-Current Assets was $42.9 million (2024), whereas its average is $42.1 million.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Non-Current Assets decreased by 18.54% in 2021 and then climbed by 21.36% in 2022.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Non-Current Assets stood at $38.8 million in 2021, then rose by 21.36% to $47.1 million in 2022, then dropped by 2.11% to $46.1 million in 2023, then decreased by 15.05% to $39.1 million in 2024, then decreased by 13.37% to $36.0 million in 2025.
  • Its Non-Current Assets was $36.0 million in Q3 2025, compared to $36.7 million in Q2 2025 and $38.1 million in Q1 2025.